PARP-1 Regulates Metastatic Melanoma through Modulation of Vimentin-induced Malignant Transformation

PLoS Genetics

Volumn 9, Issue 6, 2013, Pages

  Rodríguez, María Isabel ^a,b   Peralta Leal, Andreína ^a   O'Valle, Francisco ^b   Rodriguez Vargas, José Manuel ^a   Gonzalez Flores, Ariannys ^a   Majuelos Melguizo, Jara ^a   López, Laura ^a   Serrano, Santiago ^a   de Herreros, Antonio García ^c   Rodríguez Manzaneque, Juan Carlos ^d   Fernández, Rubén ^d   del Moral, Raimundo G ^e   de Almodóvar, José Mariano ^b   Oliver, F Javier ^a  

^a INSTITUTO DE PARASITOLOGÍA Y BIOMEDICINA LÓPEZ NEYRA   (Spain)

^b UNIVERSITY OF GRANADA   (Spain)

^c UNIVERSITAT POMPEU FABRA   (Spain)

^d PTS Granada   (Spain)

^e Unidad de Anatomía Patológica   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

NICOTINAMIDE ADENINE DINUCLEOTIDE ADENOSINE DIPHOSPHATE RIBOSYLTRANSFERASE 1; NICOTINAMIDE ADENINE DINUCLEOTIDE ADENOSINE DIPHOSPHATE RIBOSYLTRANSFERASE INHIBITOR; TRANSCRIPTION FACTOR SNAIL; UVOMORULIN; VASCULAR ENDOTHELIAL CADHERIN; VIMENTIN;

AMINO ACID SEQUENCE; ANGIOGENESIS; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CARCINOGENESIS; CELL MIGRATION; CELL MOTILITY; CONTROLLED STUDY; DOWN REGULATION; ENDOTHELIUM CELL; EPITHELIAL MESENCHYMAL TRANSITION; HUMAN; HUMAN CELL; HUMAN TISSUE; MALIGNANT TRANSFORMATION; MELANOMA; MELANOMA CELL; MONOTHERAPY; MOUSE; NONHUMAN; PHENOTYPE; PROTEIN EXPRESSION; PROTEOMICS;

ANIMALS; ANTIGENS, CD; BREAST NEOPLASMS; CADHERINS; CELL LINE, TUMOR; CELL TRANSFORMATION, NEOPLASTIC; DOGS; ENDOTHELIAL CELLS; EPITHELIAL-MESENCHYMAL TRANSITION; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMAN UMBILICAL VEIN ENDOTHELIAL CELLS; HUMANS; MCF-7 CELLS; MELANOMA, EXPERIMENTAL; MICE; NEOPLASM INVASIVENESS; NEOPLASM METASTASIS; POLY(ADP-RIBOSE) POLYMERASES; VIMENTIN;

MURINAE;

EID: 84879677739     PISSN: 15537390     EISSN: 15537404     Source Type: Journal    
DOI: 10.1371/journal.pgen.1003531     Document Type: Article

References (44)

1. Baum B, Settleman J, Quinlan MP, (2008) Transitions between epithelial and mesenchymal states in development and disease. Semin Cell Dev Biol 19: 294-308.
2. Carmeliet P, Jain RK, (2000) Angiogenesis in cancer and other diseases. Nature 407: 249-257.
3. Vestweber D, Winderlich M, Cagna G, Nottebaum AF, (2009) Cell adhesion dynamics at endothelial junctions: VE-cadherin as a major player. Trends Cell Biol 19: 8-15.
4. Radisky DC, (2005) Epithelial-mesenchymal transition. J Cell Sci 118: 4325-4326.
5. Hugo H, Ackland ML, Blick T, Lawrence MG, Clements JA, et al. (2007) Epithelial-mesenchymal and mesenchymal-epithelial transitions in carcinoma progression. J Cell Physiol 213: 374-383.
6. Thiery JP, Sleeman JP, (2006) Complex networks orchestrate epithelial-mesenchymal transitions. Nat Rev Mol Cell Biol 7: 131-142.
7. Schreiber V, Dantzer F, Ame JC, de Murcia G, (2006) Poly(ADP-ribose): novel functions for an old molecule. Nat Rev Mol Cell Biol 7: 517-528.
8. Bryant HE, Schultz N, Thomas HD, Parker KM, Flower D, et al. (2005) Specific killing of BRCA2-deficient tumours with inhibitors of poly(ADP-ribose) polymerase. Nature 434: 913-917.
9. Farmer H, McCabe N, Lord CJ, Tutt AN, Johnson DA, et al. (2005) Targeting the DNA repair defect in BRCA mutant cells as a therapeutic strategy. Nature 434: 917-921.
10. McCabe N, Turner NC, Lord CJ, Kluzek K, Bialkowska A, et al. (2006) Deficiency in the repair of DNA damage by homologous recombination and sensitivity to poly(ADP-ribose) polymerase inhibition. Cancer Res 66: 8109-8115.
11. Fong PC, Boss DS, Yap TA, Tutt A, Wu P, et al. (2009) Inhibition of poly(ADP-ribose) polymerase in tumors from BRCA mutation carriers. N Engl J Med 361: 123-134.
12. Quiles-Perez R, Munoz-Gamez JA, Ruiz-Extremera A, O'Valle F, Sanjuan-Nunez L, et al. (2010) Inhibition of poly adenosine diphosphate-ribose polymerase decreases hepatocellular carcinoma growth by modulation of tumor-related gene expression. Hepatology 51: 255-266.
13. Martin-Oliva D, Aguilar-Quesada R, O'Valle F, Munoz-Gamez JA, Martinez-Romero R, et al. (2006) Inhibition of poly(ADP-ribose) polymerase modulates tumor-related gene expression, including hypoxia-inducible factor-1 activation, during skin carcinogenesis. Cancer Res 66: 5744-5756.
14. Lacal PM, Tentori L, Muzi A, Ruffini F, Dorio AS, et al. (2009) Pharmacological inhibition of poly(ADP-ribose) polymerase activity down-regulates the expression of syndecan-4 and Id-1 in endothelial cells. Int J Oncol 34: 861-872.
15. Pyriochou A, Olah G, Deitch EA, Szabo C, Papapetropoulos A, (2008) Inhibition of angiogenesis by the poly(ADP-ribose) polymerase inhibitor PJ-34. Int J Mol Med 22: 113-118.
16. Rodriguez MI, Gonzalez-Flores A, Dantzer F, Collard J, de Herreros AG, et al. (2011) Poly(ADP-ribose)-dependent regulation of Snail1 protein stability. Oncogene 30: 4365-4372.
17. Tentori L, Muzi A, Dorio AS, Bultrini S, Mazzon E, et al. (2008) Stable depletion of poly (ADP-ribose) polymerase-1 reduces in vivo melanoma growth and increases chemosensitivity. Eur J Cancer 44: 1302-1314.
18. Bargagna-Mohan P, Hamza A, Kim YE, Khuan Abby Ho Y, Mor-Vaknin N, et al. (2007) The tumor inhibitor and antiangiogenic agent withaferin A targets the intermediate filament protein vimentin. Chem Biol 14: 623-634.
19. Gilles C, Polette M, Mestdagt M, Nawrocki-Raby B, Ruggeri P, et al. (2003) Transactivation of vimentin by beta-catenin in human breast cancer cells. Cancer Res 63: 2658-2664.
20. Kalluri R, Zeisberg M, (2006) Fibroblasts in cancer. Nat Rev Cancer 6: 392-401.
21. Vuoriluoto K, Haugen H, Kiviluoto S, Mpindi JP, Nevo J, et al. (2011) Vimentin regulates EMT induction by Slug and oncogenic H-Ras and migration by governing Axl expression in breast cancer. Oncogene 30: 1436-1448.
22. Li Y, Bhargava MM, Joseph A, Jin L, Rosen EM, et al. (1994) Effect of hepatocyte growth factor/scatter factor and other growth factors on motility and morphology of non-tumorigenic and tumor cells. In Vitro Cell Dev Biol Anim 30A: 105-110.
23. Hess AR, Seftor EA, Gruman LM, Kinch MS, Seftor RE, et al. (2006) VE-cadherin regulates EphA2 in aggressive melanoma cells through a novel signaling pathway: implications for vasculogenic mimicry. Cancer Biol Ther 5: 228-233.
24. Orsenigo F, Giampietro C, Ferrari A, Corada M, Galaup A, et al. (2012) Phosphorylation of VE-cadherin is modulated by haemodynamic forces and contributes to the regulation of vascular permeability in vivo. Nat Commun 3: 1208.
25. Maeda M, Suga T, Takasuka N, Hoshi A, Sasaki T, (1990) Effect of bis(bilato)-1,2-cyclohexanediammineplatinum(II) complexes on lung metastasis of B16-F10 melanoma cells in mice. Cancer Lett 55: 143-147.
26. Khanna C, Hunter K, (2005) Modeling metastasis in vivo. Carcinogenesis 26: 513-523.
27. Pena C, Garcia JM, Larriba MJ, Barderas R, Gomez I, et al. (2009) SNAI1 expression in colon cancer related with CDH1 and VDR downregulation in normal adjacent tissue. Oncogene 28: 4375-4385.
28. Silye R, Karayiannakis AJ, Syrigos KN, Poole S, van Noorden S, et al. (1998) E-cadherin/catenin complex in benign and malignant melanocytic lesions. J Pathol 186: 350-355.
29. Hsu M, Andl T, Li G, Meinkoth JL, Herlyn M, (2000) Cadherin repertoire determines partner-specific gap junctional communication during melanoma progression. J Cell Sci 113 (Pt 9):: 1535-1542.
30. Ivaska J, Pallari HM, Nevo J, Eriksson JE, (2007) Novel functions of vimentin in cell adhesion, migration, and signaling. Exp Cell Res 313: 2050-2062.
31. van Beijnum JR, Dings RP, van der Linden E, Zwaans BM, Ramaekers FC, et al. (2006) Gene expression of tumor angiogenesis dissected: specific targeting of colon cancer angiogenic vasculature. Blood 108: 2339-2348.
32. Min C, Eddy SF, Sherr DH, Sonenshein GE, (2008) NF-kappaB and epithelial to mesenchymal transition of cancer. J Cell Biochem 104: 733-744.
33. Wu Y, Zhang X, Salmon M, Lin X, Zehner ZE, (2007) TGFbeta1 regulation of vimentin gene expression during differentiation of the C2C12 skeletal myogenic cell line requires Smads, AP-1 and Sp1 family members. Biochim Biophys Acta 1773: 427-439.
34. Lonn P, van der Heide LP, Dahl M, Hellman U, Heldin CH, et al. (2010) PARP-1 attenuates Smad-mediated transcription. Mol Cell 40: 521-532.
35. Bertaud J, Qin Z, Buehler MJ, (2010) Intermediate filament-deficient cells are mechanically softer at large deformation: a multi-scale simulation study. Acta Biomater 6: 2457-2466.
36. Tapodi A, Debreceni B, Hanto K, Bognar Z, Wittmann I, et al. (2005) Pivotal role of Akt activation in mitochondrial protection and cell survival by poly(ADP-ribose)polymerase-1 inhibition in oxidative stress. J Biol Chem 280: 35767-35775.
37. Krengel S, Groteluschen F, Bartsch S, Tronnier M, (2004) Cadherin expression pattern in melanocytic tumors more likely depends on the melanocyte environment than on tumor cell progression. J Cutan Pathol 31: 1-7.
38. Licht AH, Muller-Holtkamp F, Flamme I, Breier G, (2006) Inhibition of hypoxia-inducible factor activity in endothelial cells disrupts embryonic cardiovascular development. Blood 107: 584-590.
39. Weis SM, Cheresh DA, (2011) Tumor angiogenesis: molecular pathways and therapeutic targets. Nat Med 17: 1359-1370.
40. Fidler IJ, (1973) Selection of successive tumour lines for metastasis. Nat New Biol 242: 148-149.
41. Melnikova VO, Bolshakov SV, Walker C, Ananthaswamy HN, (2004) Genomic alterations in spontaneous and carcinogen-induced murine melanoma cell lines. Oncogene 23: 2347-2356.
42. Chevanne M, Zampieri M, Caldini R, Rizzo A, Ciccarone F, et al. (2010) Inhibition of PARP activity by PJ-34 leads to growth impairment and cell death associated with aberrant mitotic pattern and nucleolar actin accumulation in M14 melanoma cell line. J Cell Physiol 222: 401-410.
43. Barbera MJ, Puig I, Dominguez D, Julien-Grille S, Guaita-Esteruelas S, et al. (2004) Regulation of Snail transcription during epithelial to mesenchymal transition of tumor cells. Oncogene 23: 7345-7354.
44. Singh SK, Hawkins C, Clarke ID, Squire JA, Bayani J, et al. (2004) Identification of human brain tumour initiating cells. Nature 432: 396-401.